Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents

被引：6
|
作者：
Sakurai, Toshiharu [1 ]
Nishida, Naoshi [1 ]
Kudo, Nishida Masatoshi [1 ]
机构：
[1] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2020年 / 9卷 / 06期
关键词：
COMPENSATORY PROLIFERATION; HEPATOCELLULAR-CARCINOMA; T-CELL; SORAFENIB; ACTIVATION; CANCER; DEATH;
D O I：
10.21037/hbsn.2020.03.04
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：777 / 779
页数：3
相关论文
共 50 条
  • [41] Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
    Ziyu Liu
    Yan Lin
    Jinyan Zhang
    Yumei Zhang
    Yongqiang Li
    Zhihui Liu
    Qian Li
    Ming Luo
    Rong Liang
    Jiazhou Ye
    Journal of Experimental & Clinical Cancer Research, 38
  • [42] Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition
    Lau, Peter Kar Han
    Ascierto, Paolo A.
    McArthur, Grant
    CURRENT OPINION IN IMMUNOLOGY, 2016, 39 : 30 - 38
  • [43] Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
    Liu, Ziyu
    Lin, Yan
    Zhang, Jinyan
    Zhang, Yumei
    Li, Yongqiang
    Liu, Zhihui
    Li, Qian
    Luo, Ming
    Liang, Rong
    Ye, Jiazhou
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (01)
  • [44] Patient selection for cytoreductive nephrectomy in combination with targeted therapies or immune checkpoint inhibitors
    Shapiro, Daniel D.
    Abel, E. Jason
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 513 - 520
  • [45] Promising Newer Molecular-Targeted Therapies in Head and Neck Cancer
    Lili X. Wang
    Mark Agulnik
    Drugs, 2008, 68 : 1609 - 1619
  • [46] Histone deacetylase inhibitors: A new wave of molecular targeted anticancer agents
    Budillon, Alfredo
    Di Gennaro, Elena
    Bruzzese, Francesca
    Rocco, Monia
    Manzo, Giuseppe
    Caraglia, Michele
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (02) : 119 - 134
  • [47] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe NAmaria
    Christine Spencer
    Alexandre Reuben
    Zachary ACooper
    Jennifer AWargo
    Cancer Biology & Medicine, 2014, 11 (04) : 237 - 246+213
  • [48] Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma
    Xie, Fucun
    Chen, Bowen
    Yang, Xu
    Wang, Huaiyuan
    Zhang, Ge
    Wang, Yanyu
    Wang, Yunchao
    Zhang, Nan
    Xue, Jingnan
    Long, Junyu
    Li, Yiran
    Sun, Huishan
    Xun, Ziyu
    Liu, Kai
    Chen, Xiangqi
    Song, Yang
    Yang, Xiaobo
    Lu, Zhenhui
    Mao, Yilei
    Sang, Xinting
    Lu, Yinying
    Zhao, Haitao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Combination therapy with immune checkpoint inhibitor and targeted agents in metastatic TNBC and HR-positive breast cancer
    Ozaki, Yukinori
    ANNALS OF ONCOLOGY, 2021, 32 : S267 - S267
  • [50] Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
    Teresa Kim
    Rodabe N.Amaria
    Christine Spencer
    Alexandre Reuben
    Zachary A.Cooper
    Jennifer A.Wargo
    Cancer Biology & Medicine, 2014, (04) : 237 - 246
12345